Marine Biotechnology is the field of science of producing products from aquatic organisms with the approaches of biotechnology, cell biology, molecular biology, and bioinformatics. It deals with the development of pharmaceutical drugs, enzymes and chemical products by exploring the ocean and marine resources. It is also referred to as blue biotechnology. It includes the use of techniques like bioremediation, bioprocessing, bioharvesting, and aquaculture with the application of bioreactors.
Applications of marine biotechnology include medicine, biofuels, environment, health management, reproduction, and nutrition. For example, Reproduction: Production of fish gonadotropin hormone by crude pituitary gland preparation using recombinant DNA technology, Nutrition: Transfer of glucose and hexokinase genes in the carnivorous fish for enhancing the carbohydrate uptake metabolism, Health improvement and management: Use of polymerase chain reaction (PCR) in disease diagnosis. The National Institute of Ocean Technology of India has prepared anti-aging cosmetics from deep-sea bacteria in July 2021.
As per the research, the application of sea-based ingredients in agriculture and cosmetics is in high demand fostering the marine biotechnology market growth. The nutritional supplements made from marine-derived products are in increasing demand leading to the growth of the marine biotechnology market. Discoveries and progress in the fields of aquaculture, fishery, and drug discovery development is the key driver for the market growth. Recently, Bluu Biosciences received funding for the production of fish products from cell culture. An increase in the demand and awareness of using aquatic organisms for healthy management paves way for the industry growth.
The market is segmented by type, technology, application, end-user, and region. The type segment is bifurcated into bio active substances and bio materials. The technology segment is bifurcated into isolation and cultivation of microorganisms, and culture-independent techniques. The application segment is based on aquaculture and food products, environment and human health, and drug discovery. The end-user segment is fragmented by food industry, pharmaceutical and biotechnology industry, chemical industry, and cosmetic industry. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Europe has the major share of the marine biotechnology market due to the government's support to use sea-based products. Thus the funding and investments by the government are the driving factor for the growth of the market. North America also has better and developed healthcare and research facilities coupled with biotechnology companies producing marine-based products, thus driving industry growth.
Marine Biotechnology Market Segmentation
|
Segments
|
Details
|
|
Type
|
Bio Active Substance
Bio Materials
|
|
Technology
|
Isolation and Cultivation of Microorganisms,
Culture-Independent Techniques
|
|
Application
|
Aquaculture and Food Products,
Environment & Human Health,
Drug Discovery
|
|
End-user
|
Food Industry,
Pharmaceutical and Biotechnology Industry,
Chemical Industry,
Cosmetic Industry
|
|
Region
|
North America (U.S., Canada)
Europe (Germany, France, Italy, Spain, UK,)
Asia-Pacific (Japan, China, India, Australia, South Korea)
Latin America (Mexico, Brazil, Argentina)
Middle East And Africa (Saudi Arabia, South Africa, UAE)
|
Major companies operating in the market include Sea Run Holdings Inc., NEB, Nofima, Lonza Group Ltd., Sams, Tequesta Bioventures, PharmaMar S.A., Abbott Laboratories, New England Biolabs Inc., Qingdao Codo International Ltd., Earthrise Nutritionals, NovaMatrix, GlycoMar Ltd., SEPPIC, Nutrex Hawai Inc., Royal DSM N.V., Biotech Marine, Aquapharm, Marinova, Prolume Ltd., Cyanotech Corporation, Aker Biomarine, CP Kelco US Inc.
Download Sample Report 
